These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2094 related articles for article (PubMed ID: 17658698)

  • 1. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
    Man YG; Gardner WA
    Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal degeneration of aged or injured myoepithelial cells and the resultant auto-immunoreactions are trigger factors for breast tumor invasion.
    Man YG
    Med Hypotheses; 2007; 69(6):1340-57. PubMed ID: 17493765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the "protease-centered" hypothesis.
    Man YG; Sang QX
    Exp Cell Res; 2004 Dec; 301(2):103-18. PubMed ID: 15530847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal prostate basal cell layer disruptions and leukocyte infiltration are correlated events: A potential mechanism for basal cell layer disruptions and tumor invasion.
    Man YG; Shen T; Zhao Y; Amy Sang QX
    Cancer Detect Prev; 2005; 29(2):161-9. PubMed ID: 15829376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia.
    Matsuzaki P; Cogliati B; Sanches DS; Chaible LM; Kimura KC; Silva TC; Real-Lima MA; Hernandez-Blazquez FJ; Laufer-Amorim R; Dagli ML
    J Comp Pathol; 2010 Jan; 142(1):84-8. PubMed ID: 19643431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
    Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
    Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
    Bonkhoff H; Remberger K
    Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of prostatic intraepithelial neoplasia to invasive carcinoma in C3(1)/SV40 large T antigen transgenic mice: histopathological and molecular biological alterations.
    Shibata MA; Ward JM; Devor DE; Liu ML; Green JE
    Cancer Res; 1996 Nov; 56(21):4894-903. PubMed ID: 8895741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia.
    Song Z; Wu X; Powell WC; Cardiff RD; Cohen MB; Tin RT; Matusik RJ; Miller GJ; Roy-Burman P
    Cancer Res; 2002 Sep; 62(17):5096-105. PubMed ID: 12208767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of chromogranin A, miR-146a, and miR-146b-5p in prostate structures with focally disrupted basal cell layers: an early sign of invasion and hormone-refractory cancer?
    Man YG; Fu SW; Liu AJ; Stojadinovic A; Izadjoo MJ; Chen L; Gardner WA
    Cancer Genomics Proteomics; 2011; 8(5):235-44. PubMed ID: 21980038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival.
    Bacac M; Provero P; Mayran N; Stehle JC; Fusco C; Stamenkovic I
    PLoS One; 2006 Dec; 1(1):e32. PubMed ID: 17183660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
    Man YG; Shen T; Weisz J; Berg PE; Schwartz AM; Mulshine JL; Sang QX; Nieburgs HE
    Cancer Detect Prev; 2005; 29(4):323-31. PubMed ID: 16122886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bad seeds produce bad crops: a single stage-process of prostate tumor invasion.
    Man YG; Gardner WA
    Int J Biol Sci; 2008 Aug; 4(4):246-58. PubMed ID: 18725981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia.
    Bostwick DG
    Cancer; 1996 Jul; 78(2):330-6. PubMed ID: 8674012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiation of stromal smooth muscle as a factor in prostate carcinogenesis.
    Wong YC; Tam NN
    Differentiation; 2002 Dec; 70(9-10):633-45. PubMed ID: 12492504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
    Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 105.